openPR Logo
Press release

Thalidomide Market Analysis By Market Size, Share, Growth and Forecast up to 2026

05-02-2018 09:48 AM CET | Health & Medicine

Press release from: Worldwide Market Reports

Thalidomide Market

Thalidomide Market

Worldwide Market Reports added Latest Research Report titled "Global Thalidomide Market by Manufacturers, Regions, Product Type and Application, Forecast to 2026" to its Large Report database.

Thalidomide is an immunomodulatory drug and a prototype of the thalidomide class of drugs. It is mainly used in the treatment of certain cancers (multiple myeloma) and of a complication of leprosy. It is sold under the brand name Immunoprin. It has many applications in the field of medicine. The bacterium that causes tuberculosis is related to leprosy and thalidomide may be helpful in some cases where standard TB drugs and corticosteroids are not able to resolve severe inflammation in the brain. The combination of thalidomide and dexamethasone for the treatment of multiple myeloma was approved by the U.S. Food and Drug Administration in 2006.

Ask For Sample Copy of Research Report Including TOC: https://www.worldwidemarketreports.com/sample/157663

Increasing drug and alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, presence of government funding in major markets, regulatory approvals, and product launches and services are some of the major factors driving growth of thalidomide market.

The adverse effects such as birth defects, blood clots, several cardiovascular adverse effects, liver damage, and prevention of menstruation are some of the major factors that are expected to restrain growth of thalidomide market.

Key Developments in Thalidomide Market

Key players in the market are adopting strategies such as mergers, acquisitions, and new product launches to retain its position in the thalidomide market. On April 19, 2018, Pfizer’s collaboration with Asembia was expanded. Moreover, on April 3, 2018, Pfizer partnered with Allogene Therapeutics to expand the immuno oncology portfolios of Pfizer through continued development of Allogene’s CAR T therapies. On March 20, 2018, Casi Pharmaceuticals announced US$ 50 Mn private placement to prepare the company for commercialization in China.

Get Full Table of Content of Research Report: https://www.worldwidemarketreports.com/toc/157663

Acceleron hosted Educational Webinar with leading clinicians to provide an overview of pulmonary arterial hypertension and the Sotatercept Phase 2 trial in March 2018. Moreover, bluebird bio and Celgene Corporation signed an agreement to co-develop and co-promote anti-BCMA CAR T cell therapy bb2121 in the U.S. On April 13, 2018, Allergan announced the launch of TrueTear® Intranasal Neurostimulation Device.

Some of the key players in the thalidomide market include Pfizer, Allergan, Alnylam Pharmaceuticals, Five Prime Therapeutics, Angstrom Pharmaceuticals, Acceleron Pharma, Biocon, Enzon Pharmaceuticals, Casi Pharmaceuticals, and Celgene Corporation.

Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/157663

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thalidomide Market Analysis By Market Size, Share, Growth and Forecast up to 2026 here

News-ID: 1036019 • Views:

More Releases from Worldwide Market Reports

Factors Influencing Of Immunodiagnostic Device and Reagent Market Will Show the Highest Growth Rates & Incredible Demand By 2031
Factors Influencing Of Immunodiagnostic Device and Reagent Market Will Show the …
The business intelligence report on Immunodiagnostic Device and Reagent Market defines the major trends determining this domain's growth with respect to competitive and geographical landscape. Moreover, the study covers the challenges that impede industry development and offers insights into untapped opportunities that will spur business expansion during the forecast period 2024-2031. Learn how to build a strategy to implement and a business case. Learn about Immunodiagnostic Device and Reagent market
To Register Unwavering Growth Of ICP Monitors for Intracranial Pressure Measurement Market 2024: Analysis by Current Insights,Future Dynamics and Innovative Strategies by 2031
To Register Unwavering Growth Of ICP Monitors for Intracranial Pressure Measurem …
Growing Demand of the ICP Monitors for Intracranial Pressure Measurement Market Overview 2024-2031: The latest release from WMR titled ICP Monitors for Intracranial Pressure Measurement Market Research Report 2024-2031 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the ICP Monitors for Intracranial Pressure Measurement including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles, and strategies. Global ICP Monitors
World Leading Companies involved in The Dental Lathe Market Business Outlook, Critical Insight,Opportunities, Regional Overview,Business Strategies and Industry Size Forecast to 2031
World Leading Companies involved in The Dental Lathe Market Business Outlook, Cr …
The business intelligence report on Dental Lathe Market defines the major trends determining this domain's growth with respect to competitive and geographical landscape. Moreover, the study covers the challenges that impede industry development and offers insights into untapped opportunities that will spur business expansion during the forecast period 2024-2031. Learn how to build a strategy to implement and a business case. Learn about Dental Lathe market and how it can
New Trends of Non Vascular Stent Market To Receive Overwhelming Hike In Revenue That Will Boost Overall Industry Growth,Forecast 2031
New Trends of Non Vascular Stent Market To Receive Overwhelming Hike In Revenue …
Growing Demand of the Non Vascular Stent Market Overview 2024-2031: The latest release from WMR titled Non Vascular Stent Market Research Report 2024-2031 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Non Vascular Stent including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles, and strategies. Global Non Vascular Stent Market study with 100+ market data Tables, Pie

All 5 Releases


More Releases for Thalidomide

Thalidomide Market Share Analysis 2019 | Celgene
The research study offers powerful guidelines for market players to compete well against other participants operating in the global Thalidomide market. It brings to light crucial market dynamics including drivers, challenges, restraints, trends, and opportunities. Readers are provided with detailed qualitative and quantitative analysis, PESTLE analysis, absolute dollar opportunity analysis, and Porter’s Five Forces analysis that focus on various aspects of the global Thalidomide Market. The report includes regional growth
Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity …
Worldwide Market Reports added Latest Research Report titled "Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026" to its Large Report database. Thalidomide is an immunomodulatory drug and a prototype of the thalidomide class of drugs. It is mainly used in the treatment of certain cancers (multiple myeloma) and of a complication of leprosy. It is sold under the brand name Immunoprin. It has many applications in the
Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity …
Thalidomide is an immunomodulatory drug and a prototype of the thalidomide class of drugs. It is mainly used in the treatment of certain cancers (multiple myeloma) and of a complication of leprosy. It is sold under the brand name Immunoprin. It has many applications in the field of medicine. The bacterium that causes tuberculosis is related to leprosy and thalidomide may be helpful in some cases where standard TB drugs
Global Thalidomide Market to Witness Robust Expansion by 2022
Worldwide Market Reports added Latest Research Report titled ” Global Thalidomide Market Research Report 2017 ” to its Large Report database. In this report, the global Thalidomide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue
Global Thalidomide Market 2018-2023 Pfizer, Allergan, Acceleron Pharma
Thalidomide Market Research 2018 A market study "Global Thalidomide Market" examines the performance of the Thalidomide market 2018. It encloses an in-depth Research of the Thalidomide market state and the competitive landscape globally. This report analyzes the potential of Thalidomide market in the present and the future prospects from various angles in detail. The Global Thalidomide Market 2018 report includes Thalidomide market Revenue, market Share, Thalidomide industry volume, market Trends, Thalidomide Growth
Thalidomide Market Set for Rapid Growth and Trend, by 2022
Market Study Report delivers significant information and realistic data of the Thalidomide Market. The report presents a deep study of the market growth factors and drivers. In-depth research of the Thalidomide Market limitations and the opportunities enable the user to make the future projection. This Thalidomide Market report values the industry in USD million terms for 2016, expected USD million value by the end of 2022 is provided, showing a steady